CareDx Stock Forecast
NASDAQ: CDNAHealth CareMedical SpecialitiesUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
CDNA analyst consensus
Consensus (7 analysts)
buy
Avg. price target
$58.83-6.68%
- Strong buy 0
- Buy 5
- Hold 2
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 7 Wall Street analysts covering CareDx (2026-10-07), 5 rate the stock a buy or strong buy, 2 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "buy". The average 12-month price target is $58.83, with a high estimate of $74.00 and a low estimate of $46.00. The average target implies downside of 6.7% from the current price of $63.04.
The spread between the highest and lowest targets is 60.9%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for CDNA.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 0 | 0% |
| Buy | 5 | 71% |
| Hold | 2 | 29% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-07.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $46.00 | -27.03% |
| Average target | $58.83 | -6.68% |
| High target | $74.00 | +17.39% |